Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-509-5 | CAS number: 96-48-0
Carcinogenicity
Administrative data
Description of key information
Not a carcinogen
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 900 mg/kg bw/day
Justification for classification or non-classification
The carcinogenicity of γ-Butyrolactone (GBL) has been studied in male and female F344/N rats and B6C3F1 mice (NTP, 1992). It was concluded, that there was no evidence of carcinogenic activity of GBL in male rats given 112 or 225 mg/kg or in female rats given 225 or 450 mg/kg in corn oil. There was equivocal evidence of carcinogenic activity of GBL in male mice based on marginally increased incidences of adrenal medulla pheochromocytomas and hyperplasia in the low-dose group. The sensitivity of the study in male mice to detect a carcinogenic effect was reduced by the low survival of the high-dose group associated with fighting. There was no evidence of carcinogenic activity of GBL in female mice given 262 or 525 mg/kg in corn oil. GBL is not mutagenic as determined in various in vitro and in vivo test. Based on these findings, GBL should not be rated for carcinogenicity under either the EU DSD classification system (EU Directive 67/548/EEC) or the EU CLP classification system (EU Regulation 1272/2008).
Additional information
The carcinogenicity of γ-Butyrolactone (GBL) has been studied in male and female F344/N rats and B6C3F1 mice (NTP, 1992). Doses between 0 - 525 mg/kg were used. It was concluded, that there was no evidence of carcinogenic activity of GBL in male rats given 112 or 225 mg/kg or in female rats given 225 or 450 mg/kg in corn oil. There was equivocal evidence of carcinogenic activity of GBL in male mice based on marginally increased incidences of adrenal medulla pheochromocytomas and hyperplasia in the low-dose group. The sensitivity of the study in male mice to detect a carcinogenic effect was reduced by the low survival of the high-dose group associated with fighting. There was no evidence of carcinogenic activity of GBL in female mice given 262 or 525 mg/kg in corn oil. GBL is not mutagenic as determined in various in vitro and in vivo test.
.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
